ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Healthcare Shares
ResMed shares jump 8% on stellar start to FY25
Share Market News
5 things to watch on the ASX 200 on Friday
How to invest
Here's how I'd invest $200 a month and aim for $50,000 of annual passive income
Best Shares
Top ASX shares for beginner investors to buy in October 2024
How to invest
3 steps to turn a $20k ASX share portfolio into a $5,100 yearly second income
Healthcare Shares
500 million reasons why ResMed shares are charging higher today
Value Investing
How to find ASX value shares when the market's at an all-time high
Healthcare Shares
Why is the ResMed share price taking a thumping on Thursday?
Share Market News
Why Duratec, Lotus Resources, Paladin Energy, and ResMed shares are racing higher today
Healthcare Shares
Did Apple just give ResMed shares a big long-term boost?
Healthcare Shares
2 of the top ASX healthcare shares to own right now
Share Gainers
Here are the top 10 ASX 200 shares today
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
